Last quarter (Q4 2023), Q32 Bio's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Q32 Bio's net income was $-29.40M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.16M	$ 1.16M	$ 3.21M	$ 33.97M	$ 2.70M	$ 1.67M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 1.16M	$ 1.16M	$ 3.21M	$ 33.97M	-	-
Operating Expense	$ 102.58M	$ 102.58M	$ 136.49M	$ 129.92M	$ 132.97M	$ 111.61M
Operating Income	$ -101.40M	$ -101.40M	$ -133.30M	$ -95.95M	$ -130.26M	$ -109.94M
Net Non Operating Interest Income Expense	-	-	-	-	$ 1.57M	$ 6.03M
Other Income Expense	$ -14.35M	$ -14.35M	$ -134.48M	$ -185.00K	-	-
Pretax Income	$ -87.08M	$ -87.08M	$ 1.20M	$ -95.76M	$ -128.69M	$ -103.92M
Tax Provision	$ -8.50M	$ -8.50M	$ 700.00K	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -112.96M	$ -112.96M	$ -4.99M	$ -95.76M	$ -128.69M	$ -103.92M
Basic EPS	$ -1.96	$ -1.95	$ -0.09	$ -1.73	$ -2.80	$ -2.47
Diluted EPS	$ -1.96	$ -1.95	$ -0.09	$ -1.73	$ -2.80	$ -2.47
Basic Average Shares	$ 231.34M	$ 57.83M	$ 57.40M	$ 55.28M	$ 45.91M	$ 42.12M
Diluted Average Shares	$ 231.34M	$ 57.83M	$ 57.40M	$ 55.28M	$ 45.91M	$ 42.12M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 102.58M	$ 102.58M	$ 136.49M	$ 129.92M	$ 132.97M	$ 111.61M
Net Income From Continuing And Discontinued Operation	$ -112.96M	$ -112.96M	$ -5.00M	$ -95.76M	$ -128.69M	$ -103.92M
Normalized Income	$ -47.19M	$ -85.80M	$ -130.40M	-	$ -128.69M	$ -103.92M
Interest Expense	-	-	-	-	-	-
EBIT	$ -87.08M	$ -87.08M	$ 1.20M	$ -95.76M	$ -130.26M	$ -109.94M
EBITDA	$ -89.45M	$ -89.45M	$ 544.00K	$ -88.31M	$ -122.30M	$ -103.63M

Currency in USD

Q32 Bio Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing